Researchers kill drug-resistant cancer in the lab using 50 times less chemo

CancerCell_web_1024Researchers in the US have just made an existing chemotherapy drug way more effective, managing to kill drug-resistant lung cancer cells in the lab using 50 times less of the medication than is currently required.

“That matters because we may eventually be able to treat patients with smaller and more accurate doses of powerful chemotherapy drugs, resulting in more effective treatment with fewer and milder side effects,” explained lead researcher Elena Batrakova, a pharmacologist at the University of North Carolina at Chapel Hill.

What’s really exciting about the result is that it didn’t rely on any new or experimental medications – the researchers were able to kill the drug-resistant cancer using chemotherapy that’s already been tested and is known to work in humans – all they did was make it a whole lot better by figuring out a new way to package and deliver the medication.

READ THE REST HERE

About Peter Coffaro 1091 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*